High-Grade B-Cell Lymphoma (HGBL) with MYC and BCL2 and/or BCL6 Rearrangements Is Predominantly BCL6-Rearranged and BCL6-Expressing in Taiwan
Tsai, CC; Su, YC; Bamodu, OA; Chen, BJ; Tsai, WC; Cheng, WH; Lee, CH; Hsieh, SM; Liu, ML; Fang, CL; Lin, HT; Chen, CL; Yeh, CT; Lee, WH; Ho, CL; Lai, SW; Tzeng, HE; Hsieh, YY; Chang, CL; Zheng, YM; Liu, HW; Yen, Y; Whang-Peng, J; Chao, TY
Chao, TY (corresponding author), Taipei Med Univ, Shuang Ho Hosp, Dept Internal Med, Div Hematol & Oncol, New Taipei 235, Taiwan.; Chao, TY (corresponding author), Triserv Gen Hosp, Natl Def Med Ctr, Dept Internal Med, Div Hematol Oncol, Taipei 114, Taiwan.; Chao, TY (corresponding author), Taipei Med Univ, Coll Med, Grad Inst Clin Med, Taipei 110, Taiwan.; Chao, TY (corresponding author), Taipei Med Univ, Taipei Canc Ctr, Taipei 110, Taiwan.
CANCERS, 2021; 13 (7):
